146 related articles for article (PubMed ID: 6808457)
21. Changes in serum copper and zinc during treatment with anticancer drugs interfering with pyridoxal phosphate.
Slavik M; Narasimhan TR; Riley C; Slavik J
Adv Exp Med Biol; 1989; 258():235-42. PubMed ID: 2516708
[TBL] [Abstract][Full Text] [Related]
22. Variable oral absorption of hexamethylmelamine in man.
D'Incalci M; Bolis G; Mangioni C; Morasca L; Garattini S
Cancer Treat Rep; 1978 Dec; 62(12):2117-9. PubMed ID: 109196
[TBL] [Abstract][Full Text] [Related]
23. Pentamethylmelamine: review of an aqueous analog of hexamethylmelamine.
Foster BJ; Clagett-Carr K; Hoth D; Leyland-Jones B
Cancer Treat Rep; 1986 Mar; 70(3):383-9. PubMed ID: 3082512
[TBL] [Abstract][Full Text] [Related]
24. Studies of the mode of action of antitumour triazenes and triazines-V. The correlation of the in vitro cytotoxicity and in vivo antitumour activity of hexamethylmelamine analogues with their metabolism.
Ross D; Langdon SP; Gescher A; Stevens MF
Biochem Pharmacol; 1984 Apr; 33(7):1131-6. PubMed ID: 6424683
[TBL] [Abstract][Full Text] [Related]
25. In vitro cytotoxicity of hexamethylmelamine (HMM) and its derivatives.
Dubois J; Arnould R; Abikhalil F; Hanocq M; Atassi G; Ghanem G; Libert A; Lejeune FJ
Anticancer Res; 1990; 10(3):827-32. PubMed ID: 2114821
[TBL] [Abstract][Full Text] [Related]
26. Hexamethylmelamine (altretamine). A discussion of drug action, pharmacology and clinical activity. Philadelphia, Pennsylvania, November 6, 1989. Proceedings.
Cancer Treat Rev; 1991 Mar; 18 Suppl A():1-113. PubMed ID: 1675152
[No Abstract] [Full Text] [Related]
27. Disposition and metabolism of pentamethylmelamine and hexamethylmelamine in rabbits and humans.
Ames MM; Powis G; Kovach JS; Eagan RT
Cancer Res; 1979 Dec; 39(12):5016-21. PubMed ID: 115586
[TBL] [Abstract][Full Text] [Related]
28. Hexamethylmelamine in advanced head and neck cancer. A phase II study.
Gad-El-Mawla N; Macdonald JS; Khaled H
Am J Clin Oncol; 1984 Jun; 7(3):205-8. PubMed ID: 6428214
[TBL] [Abstract][Full Text] [Related]
29. Regression of human lung tumor xenografts induced by water-soluble analogs of hexamethylmelamine.
Connors TA; Cumber AJ; Ross WC; Clarke SA; Mitchley BC
Cancer Treat Rep; 1977 Aug; 61(5):927-8. PubMed ID: 408005
[No Abstract] [Full Text] [Related]
30. Acute myelocytic leukemia in a patient treated with hexamethylmelamine.
Grubb BP; Thant M
Am J Med Sci; 1986 Dec; 292(6):393-4. PubMed ID: 3099573
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of hexamethylmelamine in intralipid following hepatic regional administration in rabbits.
Gordon IL; Kar R; Opfell RW; Wile AG
Cancer Res; 1987 Oct; 47(19):5070-3. PubMed ID: 3113728
[TBL] [Abstract][Full Text] [Related]
32. Routes of elimination of hexamethylmelamine and pentamethylmelamine in the rat.
Colombo T; Broggini M; Gescher A; D'Incalci M
Xenobiotica; 1982 May; 12(5):315-21. PubMed ID: 6814076
[TBL] [Abstract][Full Text] [Related]
33. Adriamycin, vincristine, dibromodulcitol, and hexamethylmelamine in advanced previously treated breast cancer: an ECOG pilot study.
Taylor SG; Wolter J
Med Pediatr Oncol; 1981; 9(2):187-9. PubMed ID: 6785566
[TBL] [Abstract][Full Text] [Related]
34. The curative action of hexamethylmelamine on intramuscularly or intracerebrally implanted Yoshida sarcoma.
Osswald H
Cancer Lett; 1984 Jan; 21(3):343-9. PubMed ID: 6420045
[TBL] [Abstract][Full Text] [Related]
35. Influence of ascites on the pharmacokinetics of hexamethylmelamine and N-demethylated metabolites in ovarian cancer patients.
D'Incalci M; Beggiolin G; Sessa C; Mangioni C
Eur J Cancer Clin Oncol; 1981 Dec; 17(12):1331-5. PubMed ID: 6802647
[No Abstract] [Full Text] [Related]
36. Doxorubicin-hexamethylmelamine therapy of small cell carcinoma of the lung.
Dara P; Schultz MJ; Slater LM; Armentrout SA
Cancer; 1981 Nov; 48(9):1944-6. PubMed ID: 6271385
[TBL] [Abstract][Full Text] [Related]
37. An evaluation of hexamethylmelamine, cis-diamminedichloroplatinum, and mitomycin-C in advanced breast cancer. A pilot study of the Southeastern Cancer Study Group.
Lawson D; Moore M; Smalley R
Cancer Clin Trials; 1980; 3(4):293-6. PubMed ID: 6775826
[TBL] [Abstract][Full Text] [Related]
38. Solvent, emulsifier and drug concentration factors in poly(D,L-lactic acid) microspheres containing hexamethylmelamine.
Hariharan M; Price JC
J Microencapsul; 2002; 19(1):95-109. PubMed ID: 11811763
[TBL] [Abstract][Full Text] [Related]
39. Uptake and metabolism of hexamethylmelamine and pentamethylmelamine by L5178Y lymphoblasts in vitro.
Begleiter A; Grover J; Goldenberg GJ
Cancer Res; 1980 Dec; 40(12):4489-94. PubMed ID: 6777039
[No Abstract] [Full Text] [Related]
40. Pharmacokinetics and metabolism of hexamethylmelamine in mice bearing renal cell tumors.
Dubois J; Atassi G; Hanocq M; Abikhalil F
Cancer Chemother Pharmacol; 1988; 22(4):282-8. PubMed ID: 3139314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
